176 related articles for article (PubMed ID: 32579723)
1. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: A focused review.
Prasher P; Sharma M; Aljabali AAA; Gupta G; Negi P; Kapoor DN; Singh I; Zacconi FC; de Jesus Andreoli Pinto T; da Silva MW; Bakshi HA; Chellappan DK; Tambuwala MM; Dua K
Drug Dev Res; 2020 Nov; 81(7):837-858. PubMed ID: 32579723
[TBL] [Abstract][Full Text] [Related]
2. 1,2,4-triazine analogs as novel class of therapeutic agents.
Kumar R; Sirohi TS; Singh H; Yadav R; Roy RK; Chaudhary A; Pandeya SN
Mini Rev Med Chem; 2014 Feb; 14(2):168-207. PubMed ID: 24479860
[TBL] [Abstract][Full Text] [Related]
3. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
4. Privileged s-triazines: structure and pharmacological applications.
Shah DR; Modh RP; Chikhalia KH
Future Med Chem; 2014 Mar; 6(4):463-77. PubMed ID: 24635525
[TBL] [Abstract][Full Text] [Related]
5.
Dubey P; Pathak DP; Ali F; Chauhan G; Kalaiselvan V
Curr Drug Discov Technol; 2024; 21(2):e170723218813. PubMed ID: 37461340
[TBL] [Abstract][Full Text] [Related]
6. Recent updates on 1,2,3-, 1,2,4-, and 1,3,5-triazine hybrids (2017-present): The anticancer activity, structure-activity relationships, and mechanisms of action.
Dong G; Jiang Y; Zhang F; Zhu F; Liu J; Xu Z
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200479. PubMed ID: 36372519
[TBL] [Abstract][Full Text] [Related]
7. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review.
Verma T; Sinha M; Bansal N
Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306
[TBL] [Abstract][Full Text] [Related]
8. Development, Potential Anticancer Activity and the Receptor Profile of Different Functionalized 1,3,5-Triazine Derivatives.
Sarhan MO; Motaleb MA; Ibrahim IT; Anwar MM; Zaghary WA
Mini Rev Med Chem; 2018; 18(15):1302-1320. PubMed ID: 28971773
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Activity of s-Triazine Derivatives: A Systematic Review.
Dai Q; Sun Q; Ouyang X; Liu J; Jin L; Liu A; He B; Fan T; Jiang Y
Molecules; 2023 May; 28(11):. PubMed ID: 37298753
[TBL] [Abstract][Full Text] [Related]
10. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
11. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications.
Kushwaha N; Sharma CS
Mini Rev Med Chem; 2020; 20(20):2104-2122. PubMed ID: 32727324
[TBL] [Abstract][Full Text] [Related]
12. Coumarin hybrids as novel therapeutic agents.
Sandhu S; Bansal Y; Silakari O; Bansal G
Bioorg Med Chem; 2014 Aug; 22(15):3806-14. PubMed ID: 24934993
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline-triazine derivatives.
Modh RP; De Clercq E; Pannecouque C; Chikhalia KH
J Enzyme Inhib Med Chem; 2014 Feb; 29(1):100-8. PubMed ID: 23327639
[TBL] [Abstract][Full Text] [Related]
14. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
15. Cinnamate Hybrids: A Unique Family of Compounds with Multiple Biological Activities.
Pontiki E; Peperidou A; Fotopoulos I; Hadjipavlou-Litina D
Curr Pharm Biotechnol; 2018; 19(13):1019-1048. PubMed ID: 30417783
[TBL] [Abstract][Full Text] [Related]
16. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
17. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic significance of quinolines: a patent review (2013-2015).
Hussaini SM
Expert Opin Ther Pat; 2016 Oct; 26(10):1201-21. PubMed ID: 27458877
[TBL] [Abstract][Full Text] [Related]
19. Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review.
Bareth D; Jain S; Kumawat J; Kishore D; Dwivedi J; Hashmi SZ
Bioorg Chem; 2024 Feb; 143():106971. PubMed ID: 38016395
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisinin-triazine hybrids and hybrid-dimers.
Cloete TT; de Kock C; Smith PJ; N'Da DD
Eur J Med Chem; 2014 Apr; 76():470-81. PubMed ID: 24602791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
